Mindfulness and Behavior Change to Improve Cardiovascular Health of Older People With HIV
OM-OH
3 other identifiers
interventional
50
1 country
1
Brief Summary
Older people with HIV (OPWH) are disproportionately impacted by cardiovascular disease (CVD) attributable to behavioral risk factors, and chronic HIV immune dysregulation resulting inflammation. Systemic inflammation is exacerbated by psychological distress via activating the immune response and driving pro-inflammatory CVD risk behaviors. There is promising evidence to suggest that mindfulness could be an effective intervention to reduce psychological distress and support behaviorally- and inflammatory-mediated CVD risk reduction. This project aims to refine and synthesize mindfulness and behavior change content from evidence-based protocols (mindfulness-based stress reduction and diabetes prevention program) to develop and pilot test a new text message-enhanced intervention called "One Mind One Heart" (OM-OH) using feedback from semi-structured interviews with OPWH in psychological distress (N=20), and my multidisciplinary mentorship team (Aim 1). An open pilot (N=5) with exit interviews and pre-post self-report assessments, will inform the initial acceptability of OM-OH and further refine OM-OH as needed (Aim 2). Finally, a pilot randomized controlled trial (RCT; N=50) will be conducted to a.) evaluate benchmarks of feasibility and acceptability of study methods and refined OM-OH compared to enhanced usual care, and b.) investigate potential for effects on psychological distress, inflammation, and behavioral CVD risk (Aim 3). Findings will provide the foundation for an R01 application to conduct an efficacy trial of OM-OH to reduce inflammatory-mediated CVD risk among OPWH.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable hiv
Started Jul 2025
Typical duration for not_applicable hiv
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 3, 2023
CompletedFirst Posted
Study publicly available on registry
August 21, 2023
CompletedStudy Start
First participant enrolled
July 21, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 31, 2028
September 22, 2025
September 1, 2025
2.9 years
August 3, 2023
September 17, 2025
Conditions
Outcome Measures
Primary Outcomes (9)
Feasibility of recruitment
70% or more of participants consent to screening, meet screening criteria, are eligible, and agree to participate in the study
Baseline (pre-intervention)
Feasibility of eligibility criteria
Less than 20% of participants are ineligible due to each criterion
Baseline (pre-intervention)
Feasibility of randomization
70% or more of participants are randomized and complete the first intervention session
Pre-intervention
Feasibility of the OM-OM intervention
70% or more of participants attend all sessions and complete all homework
Duration of intervention
Feasibility of research assessments
70% or more of weekly and follow-up research assessments are completed
Duration of intervention; 0 and 12-week follow-up
Feasibility of blood draws
70% of more are collected
Baseline; 12-week follow-up
Acceptability of OM-OH intervention
Rating of 7.5 or greater/10 on: session satisfaction, helpfulness, and utility; overall program satisfaction; plan to use the skills; and would recommend the intervention program to a friend
0-weeks post-intervention
Acceptability of text-enhanced delivery
Rating of 7.5 or greater/10 on: ease, and confidence of use; and rating of 2 or less/10 on interference of technical problems
0-weeks post-intervention
Acceptability of blood draws
Rating of 7.5 or greater/10 on ease of collection; and rating of 2 or less/10 on pain
0- and 12-weeks post-intervention
Secondary Outcomes (10)
Five Factor Mindfulness Questionnaire (FFMQ)
0 and 12-weeks post-intervention
Patient Health Questionnaire - 9 (PHQ-9)
0 and 12-weeks post-intervention
Generalized Anxiety Disorder - 7 (GAD-7)
0 and 12-weeks post-intervention
Perceived Stress Scale (PSS)
0 and 12-weeks post-intervention
HIV/AIDS Stress Scale
0 and 12-weeks post-intervention
- +5 more secondary outcomes
Study Arms (2)
One-Mind One-Heart
EXPERIMENTALOne-Mind One-Heart (OM-OH) is intended to be a mindfulness-based, behavior change intervention to reduce psychological and behavioral cardiovascular disease risk.
Education
ACTIVE COMPARATORThe education session will provide information on behaviors important for cardiovascular disease risk reduction.
Interventions
One-Mind One-Heart will include mindfulness and behavior change skills to address psychological distress, physical activity, diet, and substance use.
Education will be provided on behavioral cardiovascular disease risk reduction strategies, such as increasing physical activity, reducing salt intake in diet, and reduce/stop alcohol and tobacco-use.
Eligibility Criteria
You may qualify if:
- age ≥50 years
- clinical diagnosis of HIV per medical record or provision of current antiretroviral medication prescription
- viral suppression - i.e., lower than detectable limit - per medical record or provision of viral load test from the past six months
- current elevated psychological distress (score ≥10 on 10-item Kessler Psychological Distress Scale \[K10\]) screener)
- ≥1 CVD risk factor (based on ACC/AHA Atherosclerotic Cardiovascular Disease Risk Score Calculator; e.g., diabetes, current smoker, hypertension, and high cholesterol
- access to cell phone with text messaging capabilities
You may not qualify if:
- non-English-speaking
- cognitive impairments preventing informed consent
- untreated or under-treated serious mental illness (i.e., psychosis and bipolar disorder) based on clinical interview
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Psychologist
Study Record Dates
First Submitted
August 3, 2023
First Posted
August 21, 2023
Study Start
July 21, 2025
Primary Completion (Estimated)
June 30, 2028
Study Completion (Estimated)
August 31, 2028
Last Updated
September 22, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share
We plan to share aggregated data only.